Home › Stocks › STRO › All Fund Holders
STRO — SUTRO BIOPHARMA INC · All Fund Holders
Funds holding (latest): 39 · Reported value held: $157.41M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 1.12M | $37.27M | 0.00% | Add |
| Balyasny Asset Management history | Q2 2026 | 711.16K | $23.61M | 0.03% | Add |
| Geode Capital Management history | Q2 2026 | 389.69K | $12.94M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 365.97K | $12.15M | 0.01% | Add |
| Point72 Asset Management history | Q2 2026 | 237.83K | $7.90M | 0.01% | Reduce |
| UBS Group AG history | Q2 2026 | 208.51K | $6.92M | 0.00% | Reduce |
| Two Sigma Investments history | Q2 2026 | 201.69K | $6.70M | 0.01% | Add |
| Marshall Wace history | Q2 2026 | 175.25K | $5.82M | 0.01% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 159.63K | $5.32M | 0.00% | New |
| Goldman Sachs Group history | Q2 2026 | 149.22K | $4.95M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 375.79K | $4.35M | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 125.93K | $4.18M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 101.97K | $3.39M | 0.00% | Reduce |
| Janus Henderson Group history | Q4 2021 | 220.04K | $3.28M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 86.32K | $2.87M | 0.00% | Reduce |
| Arrowstreet Capital history | Q3 2024 | 737.67K | $2.55M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 57.30K | $1.90M | 0.00% | Add |
| MFS Investment Management history | Q3 2021 | 91.80K | $1.73M | 0.00% | New |
| Norges Bank Investment Management history | Q4 2022 | 206.20K | $1.67M | 0.00% | New |
| Charles Schwab Investment Management history | Q2 2026 | 49.30K | $1.64M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 41.37K | $1.37M | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 36.14K | $1.20M | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 30.13K | $1.00M | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 15.56K | $516.69K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 13.54K | $449.66K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 12.36K | $410.22K | 0.00% | Add |
| Wellington Management Group history | Q2 2026 | 10.80K | $358.56K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 7.46K | $247.54K | 0.00% | Reduce |
| AQR Capital Management history | Q1 2026 | 8.61K | $214.35K | 0.00% | Reduce |
| Franklin Resources history | Q4 2024 | 91.80K | $168.91K | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 3.46K | $114.94K | 0.00% | New |
| Baillie Gifford & Co history | Q4 2024 | 48.79K | $89.78K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 1.34K | $44.45K | 0.00% | Add |
| Principal Global Investors history | Q2 2024 | 10.85K | $31.80K | 0.00% | Reduce |
| Prudential Financial history | Q3 2025 | 35.50K | $30.82K | 0.00% | Hold |
| Manulife Financial history | Q1 2025 | 30.99K | $20.16K | 0.00% | Hold |
| PNC Financial Services history | Q2 2026 | 62 | $2.06K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 13.60K | $452 | 0.00% | New |
| Lazard Asset Management history | Q2 2025 | 10.95K | $7 | 0.00% | New |